From patients' needs to treatment outcomes in psoriasis: Results from the 'pSORRIDI' experience.
OBJECTIVE
To evaluate results of the 'pSORRIDI' experience (which is a prevention campaign to evaluate the prevalence of comorbidities, multidisciplinary needs and appropriateness of the therapeutic approach for comorbidities) in patients already being treated for psoriasis.


METHODS
Telephone interviews were conducted in patients with psoriasis, who then underwent comprehensive evaluation and investigation of comorbidities. If necessary, patients were referred to specialist cardiology, endocrinology and/or rheumatology services.


RESULTS
Overall, 72.0% (54/75) of patients required a multidisciplinary consultation. Among patients referred to cardiology, therapeutic adjustment was needed in 33.3% (five of 15) patients and a redefined diagnosis in 26.7% (four of 15) cases. Among patients undergoing endocrinology evaluations, therapeutic adjustment and a redefined diagnosis were needed in 61.1% (11/18) and 33.3% (six of 18) patients, respectively; for rheumatology evaluations, therapeutic adjustment and a redefined diagnosis were needed in 76.2% (16/21) and 19.0% (four of 21) of patients, respectively.


CONCLUSIONS
Among patients with psoriasis, there may be a need for an improvement in the diagnosis of underlying comorbid conditions, and in disease management of both psoriasis and any comorbid conditions.
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy espositomaria@virgilio.it.
Maria
M
Esposito
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Sara
S
Faleri
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Graziella
G
Babino
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Serena
S
Messinese
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Annamaria
A
Mazzotta
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Caterina
C
Schipani
Rheumatology, Allergology and Clinical Immunology, Department of Systemic Medicine, University of Rome Tor Vergata, Rome, Italy.
Maria Sole
MS
Chimenti
Department of Cardiology, University of Rome Tor Vergata, Rome, Italy.
Massimo
M
Marchei
Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy.
Stefano
S
Rizza
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Marta
M
Pandolfi
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Sergio
S
Chimenti
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Alessandro
A
Giunta
Co-morbid conditions; integrated multidisciplinary assessment; psoriasis; specialist visit
Clin Exp Dermatol. 1994 May;19(3):210-6
8033378
Dermatology. 2011;222(4):363-74
21757881
Am J Med. 2009 Dec;122(12):1150.e1-9
19958894
J Invest Dermatol. 2013 Feb;133(2):377-85
23014338
J Invest Dermatol. 2010 Jul;130(7):1785-96
20445552
Acta Dermatovenerol Croat. 2010;18(4):297-304
21251450
Semin Cutan Med Surg. 2014 Mar;33(2 Suppl 2):S20-3
24979540
Dermatologica. 1978;157(4):238-44
357213
Br J Dermatol. 2013 Sep;169(3):666-72
23647206